Views & Analysis The promising future of RNA RNA technology-based therapeutics are a new and novel way to treat diseases.
News WuXi to build new $60m clinical and manufacturing plant WuXi Biologics has pledged to invest $60 million into a new US-based site to expand its clinical and manufacturing arm.
News Novo puts $285m into monthly GLP-1 based on Ascendis tech Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, starting with a once-monthly GLP-1 receptor agonist.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
